Genotype and allele frequencies of polymorphic cytochromes P450 CYP1A2 and CYP2E1 in Mexicans

Cell Biochemistry and Function

Volumn 22, Issue 1, 2004, Pages 29-34

  Mendoza Cantú, Ania ^a   Castorena Torres, Fabiola ^a   Bermudez, Mario ^a   Martínez Hernández, Roberto ^a   Ortega, Arturo ^a   Salinas, Juan E ^b   Albores, Arnulfo ^a,c  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

CYP1A2; CYP2E1; Mexican population; Polymorphism

Indexed keywords

CYTOCHROME P450 1A2; CYTOCHROME P450 2E1;

ADULT; ARTICLE; BINDING SITE; DISEASE PREDISPOSITION; DNA DETERMINATION; DNA FLANKING REGION; DRUG METABOLISM; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; XENOBIOTIC METABOLISM;

ADOLESCENT; ADULT; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2E1; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MEXICO; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 1642454877     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.1049     Document Type: Article

References (41)

1. Koop DR. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 1992; 6: 724-730.
2. Rannug A, Alexandrie A-K, Persson I, Ingelman-Sundberg M. Genetic polymorphism of cytochrome P450 1A1, 2D6 and 2E1: regulation and toxicological significance. J Occup Environ Med 1995; 37: 25-36.
3. Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T. Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem 1999; 125: 803-808.
4. Wormhoudt LW, Commandeur JNM, Vermeulen NPE. Genetic polymorphisms of human N-acetyltranferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Crit Rev Toxicol 1999; 29: 59-124.
5. Bouchardy C, Hirvonen A, Coutelle C, Ward PJ, Dayer P, Benhamou S. Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 2000; 87: 734-740.
6. El-Zein RA, Zwischenberger JB, Abdel-Rahman SZ, Sankar AB, Au WW. Polymorphism of metabolising genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinoma. Cancer Lett 1997; 122: 71-78.
7. Tsutsumi M, Wang J-S, Takase S, Takada A. Hepatic messenger RNA content of cytochrome P4502E1 in patients with different P4502E1 genotypes. Alcohol Alcoholism 1994; 29(Suppl. 1): 29-32.
8. Murata M, Watanabe M, Yamanaka M, et al. Genetic polymorphisms in the cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett 2001; 165: 171-177.
9. Graham DE. The isolation of high molecular weight DNA from whole organisms of large tissue masses. Anal Biochem 1978; 85: 609-613.
10. Moore D. Current Protocols in Molecular Biology. John Wiley: New York, 1998; Suppl. 42 (support protocol): 2.1.3-2.1.4.
11. Hayashi SI, Watanabe J, Kawajiri K. Genetic polymorphism in the 5′-flanking region change the transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991; 110: 559-565.
12. Watanabe J, Hayashi S-I, Nakachi K, et al. Pst I and Rsa I RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Res 1990; 18: 7194.
13. Lee HC, Lee HS, Jung SH, et al. Association between polymorphisms of ethanol-metabolizing enzymes and susceptibility to alcoholic cirrhosis in a Korean male population. J Korean Med Sci 2001; 16: 745-750.
14. Chao Y-C, Young T-H, Chang W-K, Tang H-S, Hsu C-T. An investigation into whether polymorphisms of cytochrome P4502E1 are genetic markets of susceptibility to alcoholic end-stage organ damage in Chinese populations. Hepatology 1995; 22: 1409-1414.
15. Shimoda K, Someya T, Morita S, et al. Lack of impact of CYP1A2 genetic polymorphism (C/A polymorphism at position 734 in intron I and G/A polymorphism at position -2964 in the 5′-flanking region of CYP1A2) on the plasma concentrations of haloperidol in smoking male Japanese with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 261-265.
16. Raucy JL, Schultz ED, Kearins MC, et al. CYP2E1 expression in human lymphocytes from various ethnic populations. Alcohol Clin Exp Res 1999; 23: 1868-1874.
17. Wu XF, Shi HH, Jiang H, et al. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 1997; 18: 967-973.
18. Wan YJ, Poland RE, Lin KM. Genetic polymorphism of CYP2E1, ADH2, and ALDH2 in Mexican-Americans. Genet Test 1998; 2: 79-83.
19. Munoz S, Vollrath V, Vallejos MP, et al. Genetic polymorphisms of CYP2D6, CYP1A1 and CYP2E1 in the South-American population of Chile. Pharmacogenetics 1998; 8: 343-351.
20. Watanabe J, Hayashi S-I, Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the Rsa I polymorphism in the 5′-flanking region. J Biochem 1994; 116: 321-326.
21. Tsutsumi M, Wang J-S, Takada A. Genetic polymorphism of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology 1994; 107: 1430-1435.
22. Ueshima Y, Tsutsumi M, Takase S, Matsuda Y, Kawahara H. Acetaminophen metabolism in patients with different cytochrome P-4502E1 genotypes. Alcoholism Clin Exp Res 1996; 20: 25a-28a.
23. Ueno Y, Adachi J, Imamichi H, Nishimura A, Tatsuno Y. Effect of the cytochrome P-450IIE1 genotype on ethanol elimination rate in alcoholics and control subjects. Alcoholism Clin Exp Res 1996; 20: 17a-21a.
24. Krajinovic M, Sinnett H, Richer C, Labuda D, Sinnett D. Role of NQOI, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukaemia. Int J Cancer 2002; 97: 230-236.
25. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Karjalainen A, Vainio H. The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis 1993; 14: 85-88.
26. Matthias C, Bockmuhl U, Jahnke V, et al. Polymorphism in cytochrome P-450 CYP2D6, CYP1A1, CYP2E1, glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics 1998; 8: 91-100.
27. Powell H, Kitteringham NR, Pirmohamed M, Smith DA, Park BK. Expression of cytochrome CYP2E1 in human liver: assessment by mRNA, genotype and phenotype. Pharmacogenetics 1998; 8: 411-421.
28. Lucas D, Ménez C, Floch F, et al. Cytochrome P4502E1 and P4501A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic Caucasians. Alcohol Clin Exp Res 1996; 20: 1033-1037.
29. Persson I, Johansson I, Berlimng H, et al. Genetic polymorphism of cytochrome P450IIE1 in a Swedish population: relationship to incidence of lung cancer. FEBS Lett 1993; 319: 207-211.
30. Liu S, Park JY, Schantz SP, Stern JC, Lazarus P. Elucidation of CYP2E1 5′-regulatory RsaI/PstI allelic variants and their role in risk for oral cancer. Oral Oncol 2001; 37: 437-445.
31. Chung I, Bresnick E. Identification of positive and negative regulatory elements of the human cytochrome P4501A2 (CYP1A2) gene. Arch Biochem Biophys 1997; 338: 220-226.
32. Kongruttanachok N, Sukdikul S, Setavarin S, et al. Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study. BMC Cancer 2001; 1: 4.
33. Lucas D, Gill K, Ménez JF, Deitrich RA. Differences in cytochromes P450 2E1 and 1A1 between American Indians and Caucasians. Alcohol Clin Exp Res 1995; 19: 74a.
34. Pastorelli R, Bardazzi G, Saieva C, et al. Genetic determinants of alcohol addiction and metabolism: a survey in Italy. Alcohol Clin Exp Res 2001; 25: 221-227.
35. Sarmanova J, Tynkova L, Sosuva S, Gut I, Soucek P. Genetic polymorphisms of biotransformation enzymes: allele frequencies in the population of the Czech Republic. Pharmacogenet 2000; 10: 781-788.
36. Omer B, Ozbek U, Akkose A, Kilic G. Genetic polymorphism of cytochrome P450 2E1 in the Turkish population. Cell Biochem Funct 2001; 19: 273-275.
37. Anwar WA, Abdel-Rahman SZ, El-Zein RA, Mostafa HM, Au WW. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 1996; 17: 1923-1929.
38. Stephens EA, Taylor JA, Kaplan N, et al. Ethnic variation in the CYP2E1 gene, polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics 1994; 4: 185-192.
39. Griese EU, Llett KF, Kittringham NR, et al. Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia. Pharmacogenetics 2001; 11: 69-76.
40. Gattas GJ, Soares-Vieira JA. Cytochrome P450-2E1 and glutathione S-transferase mu polymorphisms among Caucasians and mulattoes from Brazil. Occup Med (Lond) 2000; 50: 508-511.
41. Quinones L, Lucas D, Godoy J, et al. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 2001; 174: 35-44.